Correlation of Nephropathy-Purpura Interval to Clinicopathologic Characteristics in Henoch-Sch(o)nlein Purpura Patients with Renal Involvement

王文荣,黎磊石,俞雨生,姚小丹,陈惠萍,刘志红

DOI: https://doi.org/10.3969/j.issn.1006-298x.2004.05.005

2004-01-01

Abstract:Objective:To study the relationship between nephropathy-purpura interval and clinical man ifestations, and prognosis in Henoch-Schnlein purpura patients with renal inv olvement (HSPN). Methodology:145 patients with HSPN who received at least an renal biopsy were followed up fo r an average time of 42.5 months. According to the record of renal damage-pur pura interval, the patients were divided to three groups: group 1(n=84), HSP N onset within one month after isolated purpura; group 2 (n=48), recurrent p urpura or purpura 1 month more proceeding HSPN; and group 3 (n=13), HSPN pro ceeding purpura. Clinical outcomes were grades as follows: Normal, i.e., symp tom free with normal urinalysis ( hematuria negative and proteinuria 0.4 g/24h r) and normal SCr;Minor urinary abnormality, i.e., proteinuria 0.4～1 g/24hr with or without hematuria, without hypertension and increased SCr;Deterioratio n, i.e., proteinuria 1 g/24hr, gross hematuria, with hypertension or renal in sufficiency. Results:Patients in group 1 showed mild urinary abnormality or isolated gross hematuria with normal blood pressure and SCr level. Renal biopsy revealed mesangial proli feration and few cellular crescent formation. Compared with groups 1, patients in group 2 developed renal damage lately. Moderate or massive proteinuria occur red more frequently in group 2. Hypoalbuminia occurred in 11 patients(22.9%) . Capsule adhesion, and cellular/fibrous crescent were more sever in group 2 th an in group 1. In group 3,hypertension was observed in 15.4% of patients, gr oss hematuria 38.5%, massive proteinuria 23.1%. Acute and chronic lesion was observed. In group 1, the outcome of 61 patients(72.6%) were graded as normal, 14 patients (16.7%) as minor urinary abnormalities,and 9 patients (10.8%) as deterioration. In group 2, the outcome of 20 patients (41.7%) were graded as normal, 14 (29.2%) as minor urinary abnormalities,and 14 (29.1%) as deteriora tion. Whereas in group 3, the outcome of 7 patients (53.8%) were greaded as n ormal, 6 (46.2%) achieved deterioration. Significant difference in probability of deterioration was found among the three groups of patients(P0.01). Conclusion:These findings suggest that interval between the onset of renal damage and purpu ra, or recurrence of purpura might be associated with the outcomes. Patients wi th recurrent purpura, or prolonged history of purpura over 1 month proceeding re nal onset, or renal onset before purpura, represent more severe subgroups of HSP .